Citations

Clear

367 citation(s) found for "Benson, Al".

Stoichiometries of Protein−Protein/DNA Binding and Conformational Changes for the Transition-State Regulator AbrB Measured by Pseudo Cell-Size Exclusion Chromatography−Mass Spectrometry
Cavanagh, John , Thompson, Richele J., Bobay, Benjamin G. , Benson, Linda M., Naylor, Stephen

Mayo Clinic

Biochemistry | July 28, 2002 | Volume: 41 | Issue: 25 | Pages: 7859-7865

10.1021/bi0202225 | PMID 12069574 Get It

Adjuvant Therapy in Rectal Cancer: Analysis of Stage, Sex, and Local Control—Final Report of Intergroup 0114
Tepper, Joel E. , Niedzwiecki, Donna , Hollis, Donna, Benson, Al B. , Gunderson, L. L., Macdonald, J. S. , Martenson, James A., O’Connell, Maria , Cummings, B., Mayer, Robert J. , Niedzwiecki, Donna

Mayo Clinic

Journal of Clinical Oncology | July 27, 2002 | Volume: 20 | Issue: 7 | Pages: 1744-1750

10.1200/jco.2002.07.132 | PMID 11919230 Get It

PURPOSE: The gastrointestinal Intergroup studied postoperative adjuvant chemotherapy and radiation therapy in patients with T3/4 and N+ rectal cancer after potentially curative surgery to try to improve chemotherapy and to determine the risk of systemic and local failure. PATIENTS AND METHODS: All patients had a potentially curative surgical resection and were treated with two cycles of chemotherapy followed by chemoradiation therapy and two additional cycles of chemotherapy. Chemotherapy regimens were bolus fluorouracil (5-FU), 5-FU and leucovorin, 5-FU and levamisole, and 5-FU, leucovorin, and levamisole. Pelvic irradiation was given to a dose of 45 Gy to the whole pelvis and a boost to 50.4 to 54 Gy. RESULTS: One thousand six hundred ninety-five patients were entered and fully assessable, with a median follow-up of 7.4 years. There was no difference in overall survival (OS) or disease-free survival (DFS) by drug regimen. DFS and OS decreased between years 5 and 7 (from 54% to 50% and 64% to 56%, respectively), although recurrence-free rates had only a small decrease. The local recurrence rate was 14% (9% in low-risk [T1 to N2+] and 18% in high-risk patients [T3N+, T4N]). Overall, 7-year survival rates were 70% and 45% for the low-risk and high-risk groups, respectively. Males had a poorer overall survival rate than females. CONCLUSION: There is no advantage to leucovorin- or levamisole-containing regimens over bolus 5-FU alone in the adjuvant treatment of rectal cancer when combined with irradiation. Local and distant recurrence rates are still high, especially in T3N+ and T4 patients, even with full adjuvant chemoradiation therapy.
Serological Expression Cloning of Novel Immunoreactive Antigens of Babesia microti
Lodes, Michael J., Houghton, Raymond L., Bruinsma, Elizabeth S. , Mohamath, Raodoh, Reynolds, Lisa D., Benson, Darin R., Krause, Peter J. , Reed, Steven G. , Persing, David H.

Mayo Clinic

Infection and Immunity | July 27, 2002 | Volume: 68 | Issue: 5 | Pages: 2783-2790

10.1128/iai.68.5.2783-2790.2000 | PMID 10768973 Get It

ABSTRACT Increased recognition of the prevalence of human babesiosis in the United States, together with rising concern about the potential for transmission of this infection by blood transfusion, has provided motivation to develop definitive serologic and molecular tests for the causative agent, Babesia microti . To develop more sensitive and specific assays for B. microti , we screened a genomic expression library with patient serum pools. This screening resulted in the identification of three classes of novel genes and an additional two novel, unrelated genes, which together encode a total of 17 unique B. microti antigens. The first class (BMN1-2 family) of genes encodes seven closely related antigens with a degenerate six-amino-acid repeat that shows limited homology to Plasmodium sp. merozoite and sporozoite surface antigens. A second class (BMN1-8 family) of genes encodes six related antigens, and the third class (BMN1-17 family) of genes encodes two related antigens. The two remaining genes code for novel and unrelated sequences. Among the three classes of antigens and remaining novel sequences, five were chosen to code for the most immunodominant antigens (BMN1-2, -9, -15, and -17 and MN-10). Western blot analysis with the resulting recombinant proteins indicated that these antigens were targets of humoral immune responses during B. microti infection in humans.
Interactions of the Nuclear Matrix-Associated Steroid Receptor Binding Factor with Its DNA Binding Element in the c-myc Gene Promoter
Sandhu, Nicole P. , Tomlinson, Andy J., Benson, Linda M., Subramaniam, Malayannan , Naylor, Stephen , Spelsberg, Thomas C., Barrett, Thomas J.

Mayo Clinic

Biochemistry | July 26, 2002 | Volume: 39 | Issue: 4 | Pages: 753-762

10.1021/bi991809v | PMID 10651641 Get It

Low temperature aqueous electrospray ionization mass spectrometry of noncovalent complexes
Veenstra, Timothy D. , Tomlinson, Andy J., Benson, Linda M., Kumar, Rajiv , Naylor, Stephen , Kumar, Rajiv

Mayo Clinic

Journal of the American Society for Mass Spectrometry | July 25, 2002 | Volume: 9 | Issue: 6 | Pages: 580-584

10.1016/s1044-0305(98)00019-1 | PMID 9879371 Get It

Effect of enzyme inhibitors on protein quaternary structure determined by on-line size exclusion chromatography-microelectrospray ionization mass spectrometry
Shen, Maryann L., Benson, Linda M., Johnson, Kenneth L. , Lipsky, James J., Naylor, Stephen

Mayo Clinic

Journal of the American Society for Mass Spectrometry | July 25, 2002 | Volume: 12 | Issue: 1 | Pages: 97-104

10.1016/s1044-0305(00)00190-2 | PMID 11142365 Get It

Utility of membrane preconcentration-capillary electrophoresis-mass spectrometry in overcoming limited sample loading for analysis of biologically derived drug metabolites, peptides, and proteins
Tomlinson, Andy J., Benson, Linda M., Jameson, Stephen C. , Naylor, Stephen , Johnson, Douglas H. , Jameson, Stephen C

Mayo Clinic

Journal of the American Society for Mass Spectrometry | July 25, 2002 | Volume: 8 | Issue: 1 | Pages: 15-24

10.1016/s1044-0305(96)00133-x Get It